ARRY-382 is a potent, oral and highly selective inhibitor of CSF1R/c-Fms with an IC50 of 9 nM. ARRY-382 can be used for the research of advanced or metastatic cancers[1].
Molecular Weight:
564.68
Purity:
99.95
CAS Number:
[1313407-95-2]
Formula:
C32H36N8O2
Target:
c-Fms
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted